State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2 Publisher Pubmed

Derakhshan MA^{1, 2} ; Amani A³ ; Faridimajidi R⁴

Source: ACS Applied Materials and Interfaces Published:2021

Abstract

The pandemic outbreak of SARS-CoV-2, with millions of infected patients worldwide, has severely challenged all aspects of public health. In this regard, early and rapid detection of infected cases and providing effective therapeutics against the virus are in urgent demand. Along with conventional clinical protocols, nanomaterial-based diagnostics and therapeutics hold a great potential against coronavirus disease 2019 (COVID-19). Indeed, nanoparticles with their outstanding characteristics would render additional advantages to the current approaches for rapid and accurate diagnosis and also developing prophylactic vaccines or antiviral therapeutics. In this review, besides presenting an overview of the coronaviruses and SARS-CoV-2, we discuss the introduced nanomaterial-based detection assays and devices and also antiviral formulations and vaccines for coronaviruses. ©

Related Docs

View other Related Docs

1. Nanostructures for Prevention, Diagnosis, and Treatment of Viral Respiratory Infections: From Influenza Virus to Sars-Cov-2 Variants, Journal of Nanobiotechnology (2023)

2. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)

3. The Quest for a Better Fight: How Can Nanomaterials Address the Current Therapeutic and Diagnostic Obstacles in the Fight Against Covid-19?, Journal of Drug Delivery Science and Technology (2022)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (3)

Rassoul Dinarvand (2)

Other Related Docs

4. Nanotheranostics Against Covid-19: From Multivalent to Immune-Targeted Materials, Journal of Controlled Release (2020)

5. Current Advances and Challenges in Covid-19 Vaccine Development: From Conventional Vaccines to Next-Generation Vaccine Platforms, Molecular Biology Reports (2022)

6. Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid), International Journal of Molecular Sciences (2021)

7. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)

8. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)

9. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)

10. Vaccines for Covid-19: A Systematic Review of Feasibility and Effectiveness, Infectious Disorders - Drug Targets (2022)

11. Biomarker Based Biosensors: An Opportunity for Diagnosis of Covid-19, Reviews in Medical Virology (2022)

12. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)

13. The Significance of Bioengineered Nanoplatforms Against Sars-Cov-2: From Detection to Genome Editing, Life Sciences (2021)

14. Therapeutic and Diagnostic Applications of Nanoparticles in the Management of Covid-19: A Comprehensive Overview, Virology Journal (2022)

15. Green Chemistry and Coronavirus, Sustainable Chemistry and Pharmacy (2021)

16. Quantum Dots Against Sars-Cov-2: Diagnostic and Therapeutic Potentials, Journal of Chemical Technology and Biotechnology (2022)

17. Nanobiocide Based-Silver Nanomaterials Upon Coronaviruses: Approaches for Preventing Viral Infections, Nanoscale Research Letters (2021)

18. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)

19. Point-Of-Use Rapid Detection of Sars-Cov-2: Nanotechnology-Enabled Solutions for the Covid-19 Pandemic, International Journal of Molecular Sciences (2020)

20. Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine, International Immunopharmacology (2020)

Style	Citing Format
MLA	Derakhshan MA, Amani A, Faridimajidi R. "State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2." ACS Applied Materials and Interfaces, vol. 13, no. 13, 2021, pp. 14816-14843.
APA	Derakhshan MA, Amani A, Faridimajidi R (2021). State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2. ACS Applied Materials and Interfaces, 13(13), 14816-14843.
Chicago	Derakhshan MA, Amani A, Faridimajidi R. "State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2." ACS Applied Materials and Interfaces 13, no. 13 (2021): 14816-14843.
Harvard	Derakhshan MA, Amani A, Faridimajidi R (2021) 'State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2', ACS Applied Materials and Interfaces, 13(13), pp. 14816-14843.
Vancouver	Derakhshan MA, Amani A, Faridimajidi R. State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2. ACS Applied Materials and Interfaces. 2021;13(13):14816-14843.
BibTex	@article{ author = {Derakhshan MA and Amani A and Faridimajidi R}, title = {State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2}, journal = {ACS Applied Materials and Interfaces}, volume = {13}, number = {13}, pages = {14816-14843}, year = {2021} }
RIS	TY - JOUR AU - Derakhshan MA AU - Amani A AU - Faridimajidi R TI - State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2 JO - ACS Applied Materials and Interfaces VL - 13 IS - 13 SP - 14816 EP - 14843 PY - 2021 ER -

Science Communicator Platform

Authors

Abstract